Bristol Myers Squibb (BMY) Buildings (2015 - 2026)

Bristol Myers Squibb (BMY) has 12 years of Buildings data on file, last reported at $7.5 billion in Q1 2026.

• Buildings for Q1 2026 came in at $7.5 billion, up 12.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 billion (up 12.74% YoY), and the FY2025 annual result was $7.3 billion, up 10.47% from the prior year.
• Buildings grew to $7.5 billion in Q1 2026 per BMY's latest filing, from $7.3 billion in the prior quarter.
• Over five years, Buildings peaked at $7.5 billion in Q1 2026 and troughed at $5.7 billion in Q2 2022.
• A 5-year average of $6.5 billion and a median of $6.5 billion in 2023 frame the typical range for Buildings.
• The sharpest annual moves came in 2022 and 2026: Buildings climbed 0.09% in 2022, then gained 12.74% in 2026.
• A 5-year view of Buildings shows it stood at $5.9 billion in 2022, then increased by 9.71% to $6.5 billion in 2023, then rose by 1.32% to $6.6 billion in 2024, then rose by 10.47% to $7.3 billion in 2025, then rose by 2.97% to $7.5 billion in 2026.
• Business Quant data shows BMY's Buildings at $7.5 billion in Q1 2026, $7.3 billion in Q4 2025, and $7.1 billion in Q3 2025.